Financial Summary (All financials)
| In millions, except per share items | Mar-31-22 | Mar-31-21 | Mar-31-20 | Mar-31-19 | Mar-31-18 | Mar-31-17 |
| Revenues | 231.0 | 59.3 | 0.0 | 0.0 | 0.0 | -27.7 |
| Revenue growth | 289.4% | | | | -100.0% | |
| Cost of goods sold | 51.6 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 179.4 | 57.4 | 0.0 | 0.0 | 0.0 | -27.7 |
| Gross margin | 77.7% | 96.7% | | | | 100.0% |
| Selling, general and administrative | 259.4 | 181.4 | 82.3 | 42.2 | | |
| Research and development | 107.4 | 136.7 | 192.6 | 222.6 | 116.8 | 43.5 |
| General and administrative | | | | | 24.2 | 12.4 |
| EBIT | -187.3 | -260.8 | -274.9 | -264.8 | -141.1 | -83.5 |
| EBIT margin | -81.1% | -439.6% | | | | 302.0% |
| Pre-tax income | -200.9 | -254.8 | -288.2 | -273.1 | -143.0 | -83.5 |
| Income taxes | 5.0 | 0.3 | 0.8 | 0.5 | 0.2 | -0.1 |
| Tax rate | | | | | | 0.1% |
| Net income | -206.0 | -255.1 | -289.0 | -273.6 | -143.3 | -83.4 |
| Net margin | -89.2% | -430.1% | | | | 301.7% |
| |
| Diluted EPS | ($2.22) | ($2.83) | ($3.37) | ($4.09) | ($2.41) | ($1.70) |
| Shares outstanding (diluted) | 93.0 | 90.0 | 85.8 | 66.9 | 59.5 | 49.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|